Antoine YRONDI

PU-PH

Travaille sur

Publications rédigées ou co-rédigées

> 65- Mise en Abyme of Post-Traumatic Stress Disorder and Infantile Regression Revealed by Intracranial Electrical Stimulation in Epilepsy.
Robin A, Barbeau EJ, Denuelle M, Guillen A, De Barros A, Sol JC, Mirabel H, Lotterie JA, Yrondi A, Rulquin F, Valton L, Curot J.
Brain Stimul. 2024 Aug 16:S1935-861X(24)00145-1. doi: 10.1016/j.brs.2024.08.004.
> 41- Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.
Argyelan M, Deng ZD, Ousdal OT, Oltedal L, Angulo B, Baradits M, Spitzberg AJ, Kessler U, Sartorius A, Dols A, Narr KL, Espinoza R, van Waarde JA, Tendolkar I, van Eijndhoven P, van Wingen GA, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Paulson OB, Yrondi A, Péran P, Soriano-Mas C, Cardoner N, Cano M, van Diermen L, Schrijvers D, Belge JB, Emsell L, Bouckaert F, Vandenbulcke M, Kiebs M, Hurlemann R, Mulders PC, Redlich R, Dannlowski U, Kavakbasi E, Kritzer MD, Ellard KK, Camprodon JA, Petrides G, Malhotra AK, Abbott CC.
Mol Psychiatry. 2024 Feb;29(2):229-237. doi: 10.1038/s41380-023-02318-2.
> 10- Structural and functional changes associated with functional/dissociative seizures: A review of the literature.
Hassan J, Taib S, Yrondi A.
Epilepsy Behav. 2024 Jan 27;152:109654. doi: 10.1016/j.yebeh.2024.109654.
> 8- [Use of antidepressants in unipolar depression in the elderly].
Pericaud A, Straczek C, Montastruc F, Leboyer M, Yrondi A, Arbus C.
Encephale. 2022 Feb 10:S0013-7006(22)00006-9. doi: 10.1016/j.encep.2021.11.006.
> 1- How to deprescribe esketamine in resistant depression? A point of view after first clinical uses.
Taillefer de Laportalière T, Yrondi A, Jullien A, Cestac P, Montastruc F.
Epidemiol Psychiatr Sci. 2022 Jan 11;31:e4. doi: 10.1017/S204579602100072X.
> 88- Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics.
Levy A, El-Hage W, Bennabi D, Allauze E, Bouvard A, Camus V, Courtet P, Dorey JM, Etain B, Fond G, Genty JB, Holtzmann J, Horn M, Leboyer M, Llorca PM, Meyrel M, Molière F, Nguon AS, Petrucci J, Rey R, Richieri R, Stephan F, Vaiva G, Walter M, Haffen E, Aouizerate B, Yrondi A.
Front Psychiatry. 2021 Dec 6;12:795666. doi: 10.3389/fpsyt.2021.795666. eCollection 2021.
> 83- Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale
Javelot H, Meyer G, Becker G, Post G, Runge V, Pospieszynski P, Schneiderlin T, Armand-Branger S, Michel B, Weiner L, Faria CGF, Drapier D, Fakra E, Fossati P, Haffen E, Yrondi A, Hingray C.
Encephale. 2021 Dec 4:S0013-7006(21)00227-X. doi: 10.1016/j.encep.2021.09.004.
> 82- Changes in Cannabis Consumption During the Global COVID-19 Lockdown: The International COVISTRESS Study.
Salles J, Yrondi A, Marhar F, Andant N, Dorlhiac RA, Quach B, Jiao J, Antunes S, Ugbolue UC, Guegan J, Rouffiac K, Pereira B; COVISTRESS Network, Clinchamps M, Dutheil F.
Front Psychiatry. 2021 Nov 11;12:689634. doi: 10.3389/fpsyt.2021.689634.
> 70- Comparative effects of 15 antidepressants on the risk of Withdrawal Syndrome: A real-world study using the WHO pharmacovigilance database.
Quilichini JB, Revet A, Garcia P, Bouquié R, Hamard J, Yrondi A, Montastruc F.
J Affect Disord. 2021 Oct 23:S0165-0327(21)01125-3. doi: 10.1016/j.jad.2021.10.041.
> 66- Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research Collaboration.
Takamiya A, Dols A, Emsell L, Abbott C, Yrondi A, Soriano Mas C, Jorgensen MB, Nordanskog P, Rhebergen D, van Exel E, Oudega ML, Bouckaert F, Vandenbulcke M, Sienaert P, Péran P, Cano M, Cardoner N, Jorgensen A, Paulson OB, Hamilton P, Kampe R, Bruin W, Bartsch H, Ousdal OT, Kessler U, van Wingen G, Oltedal L, Kishimoto T.
Schizophr Bull. 2021 Oct 8:sbab122. doi: 10.1093/schbul/sbab122. Online ahead of print.
PMID: 34624103
> 60- Teaching emergency situations during a psychiatry residency programme using a blended learning approach: a pilot study.
Salles J, Birmes P, Schmitt L, Bastiani B, Soto M, Lafont-Rapnouil S, Mathur A, Bougon E, Arbus C, Yrondi A.
BMC Med Educ. 2021 Sep 6;21(1):473. doi: 10.1186/s12909-021-02887-2.
> 54- Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology.
Javelot H, Gitahy Falcao Faria C, Vandenberghe F, Dizet S, Langrée B, Le Maout M, Straczek C, Egron A, Erb A, Sujol G, Yrondi A, Weibel S, Vincent PD, Meyer G, Hingray C.
Pharmacy (Basel). 2021 Aug 21;9(3):146. doi: 10.3390/pharmacy9030146.
> 46- Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial.
Roullet P, Vaiva G, Véry E, Bourcier A, Yrondi A, Dupuch L, Lamy P, Thalamas C, Jasse L, El Hage W, Birmes P.
Neuropsychopharmacology. 2021 Aug;46(9):1643-1649. doi: 10.1038/s41386-021-00984-w.
> 26- Case Report: Use of Subcutaneous Midazolam During an Episode of Catatonia.
Raymond V, Véry E, Jullien A, Eyvrard F, Anguill L, Yrondi A.
Front Psychiatry. 2021 Apr 14;12:666646. doi: 10.3389/fpsyt.2021.666646.
> 25- Clinical features and outcomes of COVID-19 patients hospitalized for psychiatric disorders: a French multi-centered prospective observational study.
Dobre D, Schwan R, Jansen C, Schwitzer T, Martin O, Ligier F, Rolland B, Abdel-Ahad P, Capdevielle D, Corruble E, Delamilleure P, Dollfus S, Drapier D, Bennabi D, Joubert F, Lecoeur W, Massoubre C, Pelissolo A, Roser M, Schmitt C, Teboul N, Vansteene C, Yekhlef W, Yrondi A, Haoui R, Gaillard R, Leboyer M, Thomas P, Gorwood P, Laprevote V.
Psychol Med. 2021 Apr 27:1-29. doi: 10.1017/S0033291721001537.
> 22- Relationship between childhood physical abuse and clinical severity of treatment-resistant depression in a geriatric population.
Yrondi A, Arbus C, Bennabi D, D’Amato T, Bellivier F, Bougerol T, Camus V, Courtet P, Doumy O, Genty JB, Holtzmann J, Horn M, Lancon C, Leboyer M, Llorca PM, Maruani J, Moirand R, Molière F, Petrucci J, Richieri R, Samalin L, Stephan F, Vaiva G, Walter M; FondaMental Advanced Centres of Expertise in Resistant Depression (FACE-DR) Collaborators, Haffen E, Aouizerate B, El-Hage W.
PLoS One. 2021 Apr 20;16(4):e0250148. doi: 10.1371/journal.pone.0250148.
> 45- The neural correlates of the visual consciousness in schizophrenia: an fMRI study.
Lefebvre S, Very E, Jardri R, Horn M, Yrondi A, Delmaire C, Rascle C, Dujardin K, Thomas P, Pins D.
Voir la publication
Eur Arch Psychiatry Clin Neurosci. 2020 Aug 19. doi: 10.1007/s00406-020-01167-2. Online ahead of print.
> 41- Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2.
Sauvaget A, Dumont R, Bukowski N, Bonnot O, Auffret R, Poulet E, Szekely D, Quiles C, Yrondi A, Plaze M, de Carvalho W, Amad A, Bulteau S.
Voir la publication
Encephale. 2020 Jun;46(3S):S119-S122. doi: 10.1016/j.encep.2020.05.008. Epub 2020 Jun 4. French.
> 30- Post-traumatic Stress Disorder With Flashbacks of an Old Childhood Memory Triggered by Right Temporal Lobe Epilepsy Surgery in Adulthood.
Yrondi A, Valton L, Bouilleret V, Aghakhani N, Curot J, Birmes PJ.
Voir la publication
Front Psychiatry. 2020 Apr 28;11:351. doi: 10.3389/fpsyt.2020.00351. eCollection 2020.
> 17- Posttraumatic Stress Disorder Symptoms in Lymphoma Patients: A Prospective Study.
Camille C, Dimeglio C, Yrondi A, Compaci G, Delmas E, Gauché M, Laurent G, Birmes P.
Voir la publication
Front Psychiatry. 2020 Mar 11;11:201. doi: 10.3389/fpsyt.2020.00201. eCollection 2020.
> 61- Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode.
Samalin L, Yrondi A, Charpeaud T, Genty JB, Blanc O, Sauvaget A, Stéphan F, Walter M, Bennabi D, Bulteau S, Haesebaert F, D’Amato T, Poulet E, Holtzmann J, Richieri RM, Attal J, Nieto I, El-Hage W, Bellivier F, Schmitt L, Lançon C, Bougerol T, Leboyer M, Aouizerate B, Haffen E, Courtet P, Llorca PM.
Voir la publication
J Affect Disord. 2020 Mar 1;264:318-323. doi: 10.1016/j.jad.2020.01.004.
> Childhood Trauma increases suicidal behaviour in a treatment-resistant depression population: a FACE-DR report.
Yrondi A, Vaiva G, Walter M, D Amato T, Bellivier F, Bennabi D, Bougerol T, Camus V, Doumy O, Genty JB, Haffen E, Holtzmann J, Horn M, Lançon C, Leboyer M, Llorca PM, Maruani J, Moirand R, Molière F, Petrucci J, Richieri R, Samalin L, Schmitt L, Stephan F; FondaMental Advanced Centers of Expertise in Resistant Depression (FACE-DR); List of FondaMental Advanced Centre of Expertise (FACE-DR) collaborators; FACE-DR Clinical Sites and Principal Collaborators in France.
Voir la publication
J Psychiatr Res. 2020 Dec 23;135:20-27. doi: 10.1016/j.jpsychires.2020.12.055.
> 60- Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.
Garcia P, Revet A, Yrondi A, Rousseau V, Degboe Y, Montastruc F.
Voir la publication
Drug Saf. 2020 Dec;43(12):1315-1322. doi: 10.1007/s40264-020-01013-3.
> 50- Significant Decrease in Hippocampus and Amygdala Mean Diffusivity in Treatment-Resistant Depression Patients Who Respond to Electroconvulsive Therapy.
Yrondi A, Nemmi F, Billoux S, Giron A, Sporer M, Taib S, Salles J, Pierre D, Thalamas C, Schmitt L, Péran P, Arbus C.
Front Psychiatry. 2019 Sep 19;10:694. doi: 10.3389/fpsyt.2019.00694. Voir la publication
> 46- Traumatic Hystero-Neurasthenia in Professor Charcot’s Leçons du Mardi
Yrondi A, Taib S, Dupuch L, Schmitt L, Very E, Birmes P.
J Nerv Ment Dis. 2019 Sep;207(9):799-804. doi: 10.1097
> 45- Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental
Bennabi D, Charpeaud T, Yrondi A, Genty JB, Destouches S, Lancrenon S, Alaïli N, Bellivier F, Bougerol T, Camus V, Dorey JM, Doumy O, Haesebaert F, Holtzmann J, Lançon C, Lefebvre M, Moliere F, Nieto I, Rabu C, Richieri R, Schmitt L, Stephan F, Vaiva G, Walter M, Leboyer M, El-Hage W, Llorca PM, Courtet P, Aouizerate B, Haffen E. BMC Psychiatry. 2019 Aug 28;19(1):262. doi: 10.1186/s12888-019-2237-x
> 44- Grey Matter changes in treatment-resistant depression during electroconvulsive therapy.
Yrondi A, Nemmi F, Billoux S, Giron A, Sporer M, Taib S, Salles J, Pierre D, Thalamas C, Rigal E, Danet L, Pariente J, Schmitt L, Arbus C, Péran P.
Voir la publication
J Affect Disord. 2019 Jul 31;258:42-49. doi: 10.1016/j.jad.2019.07.075.
> 40- Mood disorders: When should we use repetitive transcranial magnetic stimulation?
Bulteau S, Guirette C, Brunelin J, Poulet E, Trojak B, Richieri R, Szekely D, Bennabi D, Yrondi A, Rotharmel M, Bougerol T, Dall’Igna G, Attal J, Benadhira R, Bouaziz N, Bubrovszky M, Calvet B, Dollfus S, Foucher J, Galvao F, Gay A, Haesebaert F, Haffen E, Jalenques I, Januel D, Jardri R, Millet B, Nathou C, Nauczyciel C, Plaze M, Rachid F, Vanelle JM, Sauvaget A.
Voir la publication
Presse Med. 2019 Jun;48(6):625-646. doi: 10.1016/j.lpm.2019.01.012. Epub 2019 May 31. Review. French
> 36- Suicidal Ideation and Traumatic Exposure Should Not Be Neglected in Epileptic Patients: A Multidimensional Comparison of the Psychiatric Profile of Patients Suffering From Epilepsy and Patients Suffering From Psychogenic Nonepileptic Seizures.
Guillen A, Curot J, Birmes PJ, Denuelle M, Garès V, Taib S, Valton L, Yrondi A.
Front Psychiatry. 2019 May 3;10:303. doi: 10.3389/fpsyt.2019.00303. eCollection 2019.
> 56- Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental.
Bennabi D, Charpeaud T, Yrondi A, Genty JB, Destouches S, Lancrenon S, Alaïli N, Bellivier F, Bougerol T, Camus V, Dorey JM, Doumy O, Haesebaert F, Holtzmann J, Lançon C, Lefebvre M, Moliere F, Nieto I, Rabu C, Richieri R, Schmitt L, Stephan F, Vaiva G, Walter M, Leboyer M, El-Hage W, Llorca PM, Courtet P, Aouizerate B, Haffen E.
Voir la publication
BMC Psychiatry. 2019 Aug 28;19(1):262. doi: 10.1186/s12888-019-2237-x.
> 14- Symptoms of depression and post-traumatic stress in a group of lightning strike victims.
Yrondi A, DerKasbarian R, Gallini A, Max V, Pauron C, Joubin A, Laguerre J, Virenque C, Birmes P.
J Psychosom Res. 2019 May;120:90-95. doi: 10.1016/j.jpsychores.2019.03.012.
> 59- The Prevalence of Hepatitis E in a Patient Cohort Presenting With Addictive Injection Behavior.
Yrondi A, Salles J, Péron JM, Sporer M, Taib S, Gallini A, Noilhan C, Dimeglio C, Entajan F, Crequy M, Izopet J, Schmitt L.
Voir la publication
Front Psychiatry. 2019 Nov 12;10:832. doi: 10.3389/fpsyt.2019.00832.
> 45- Work satisfaction and exhaustion among psychiatrists in psychiatric emergency services.
Very E, Moncany AH, Yrondi A, Marquet T, Bui E, Schmitt L.
Encephale. 2018 Apr;44(2):106-110. doi: 10.1016/j.encep.2016.10.001. Epub 2016 Nov 18. French.
> 32- Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study).
Lloret-Linares C, Daali Y, Chevret S, Nieto I, Molière F, Courtet P, Galtier F, Richieri RM, Morange S, Llorca PM, El-Hage W, Desmidt T, Haesebaert F, Vignaud P, Holtzmann J, Cracowski JL, Leboyer M, Yrondi A, Calvas F, Yon L, Le Corvoisier P, Doumy O, Heron K, Montange D, Davani S, Déglon J, Besson M, Desmeules J, Haffen E, Bellivier F.
BMC Pharmacol Toxicol. 2017 Nov 7;18(1):70. doi: 10.1186/s40360-017-0173-2.
> 38- Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study).
Yrondi A, Aouizerate B, El-Hage W, Moliere F, Thalamas C, Delcourt N, Sporer M, Taib S, Schmitt L, Arlicot N, Meligne D, Sommet A, Salabert AS, Guillaume S, Courtet P, Galtier F, Mariano-Goulart D, Champfleur NM, Bars EL, Desmidt T, Lemaire M, Camus V, Santiago-Ribeiro MJ, Cottier JP, Fernandez P, Meyer M, Dousset V, Doumy O, Delhaye D, Capuron L, Leboyer M, Haffen E, Péran P, Payoux P, Arbus C.
Front Psychiatry. 2018 Jul 24;9:326. doi: 10.3389/fpsyt.2018.00326. eCollection 2018.
> 57- Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review.
Yrondi A, Sporer M, Péran P, Schmitt L, Arbus C, Sauvaget A.
Brain Stimul. 2017 Oct 19. pii: S1935-861X(17)30946-4. doi: 10.1016/j.brs.2017.10.013.
> 47- Depression and sports-related concussion: A systematic review.
Yrondi A, Brauge D, LeMen J, Arbus C, Pariente J.
Presse Med. 2017 Sep 14. pii: S0755-4982(17)30372-X. doi: 10.1016/j.lpm.2017.08.013.
> 64- Structural-functional brain changes in depressed patients during and after electroconvulsive therapy.
Yrondi A, Péran P, Sauvaget A, Schmitt L, Arbus C.
Acta Neuropsychiatr. 2016 Nov 23:1-12.
> 63- [Work satisfaction and exhaustion among psychiatrists in psychiatric emergency services].
Very E, Moncany AH, Yrondi A, Marquet T, Bui E, Schmitt L.
Encephale. 2016 Nov 18. pii: S0013-7006(16)30210-X. doi: 10.1016/j.encep.2016.10.001. [Epub ahead of print] French.
> 50- [Mood disorders and epilepsy surgery: A review].
Yrondi A, Arbus C, Valton L, Schmitt
L.Encephale. 2016 Jun 2. pii: S0013-7006(16)30082-3. doi: 10.1016/j.encep.2016.02.015. [Epub ahead of print] French.
> 49- [« Alice in wonderland syndrome », a precursor of depressive disorder with melancholic characteristics].
Yrondi A, Schmitt L, Arbus C.
Encephale. 2016 May 9. pii: S0013-7006(16)30069-0. doi: 10.1016/j.encep.2016.03.013. [Epub ahead of print] French. No abstract available.